Tuesday, October 21, 2014

Third Point Wants Amgen to Explore Separation

Activist investor Dan Loeb revealed his Third Point has built a stake in biotech company Amgen and is calling on it to explore breaking into two businesses, according to a letter he sent to Third Point’s investors.



from WSJ.com: US Business http://ift.tt/1yhRSuJ

via IFTTT

No comments:

Post a Comment